ArticleJACC. Case reports2025
Radial Approach Renal Denervation: A First-in-Man Case With the 4-F TIVUS Catheter.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Renal Denervation in Cardiovascular Diseases: Mechanisms, Evidence, and Expanding Applications.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026Review
- Ten-Year Results of Therapeutic Intravascular Ultrasound Renal Denervation in Resistant Hypertension: A Prospective Single-Center Study.Kidney & blood pressure research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRenal denervation (RDN) is an effective procedure for the treatment of uncontrolled hypertension, typically performed via the femoral approach. Although RDN is generally safe, vascular complications remain the most frequent adverse events. CASE SUMMARY: A 57-year-old man with resistant hypertension was enrolled in the Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study (REDUCED 1) clinical study. He underwent bilateral RDN using a novel 4-F ultrasound-based catheter via left radial arterial access. The procedure was uneventful, and at 3-month follow-up, ambulatory and office blood pressure showed marked reductions. DISCUSSION: This first-in-human case supports the feasibility and safety of transradial RDN using a dedicated 4-F ultrasound catheter. The radial approach may reduce access-site complications and enable same-day discharge. Future studies are needed to confirm the benefits of this system. TAKE-HOME MESSAGE: Transradial RDN using a novel 4-F ultrasound catheter is safe, feasible, and may offer procedural and patient-care advantages over femoral access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.